| ²é¿´: 2327 | »Ø¸´: 2 | ||
yyzhyfľ³æ (СÓÐÃûÆø)
|
[ÇóÖú]
¹ØÓÚtracked for impact factorµÄÎÊÌâ
|
|
|
ÎÄÕÂͶBMC medicine ±»¾Ü£¬¾Ü¸åÐŽ¨ÒéÎÒתͶBMC Endocrine Disorders£¬ÎÒ¿´ÁËһϣ¬Õâ¸öÆÚ¿¯´¦ÔÚtracked for impact factor µÄ״̬¡£Çë½Ìһϸ÷λÐǪ̈£¬Õâ¸öÊÇʲôÒâ˼£¿ÊÇ˵Õâ¸öÆÚ¿¯ÒѾ±»SCIÊÕ¼µ«ÊÇ»¹Ã»´ïµ½3Ä꣬ËùÒÔÔÝʱûÓÐÓ°ÏìÒò×Óô£¿ÖµµÃͶ¸øÕâ¸öÔÝʱûÓÐÓ°ÏìÒò×ÓµÄÆÚ¿¯Ã´ лл¸÷λ |
» ²ÂÄãϲ»¶
309Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
ÇóÉúÎïѧѧ˶µ÷¼Á¡ª¡ª364·Ö
ÒѾÓÐ3È˻ظ´
277¹¤¿ÆÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸ÎäÀí²ÄÁϹ¤³Ì302µ÷¼Á»·»¯»ò»¯¹¤
ÒѾÓÐ17È˻ظ´
359Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸¹þ¶û±õ¹¤Òµ´óѧ085600Ó¢Ò»Êý¶þ337·ÖÇóµ÷¼Á
ÒѾÓÐ11È˻ظ´
0703×Ü·Ö331Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
¿¼ÑÐÉúÎïѧ¿¼AÇø211£¬³õÊÔ322£¬¿ÆÄ¿Éú»¯ºÍÉúÎï×ۺϣ¬Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Ò»Ö¾Ô¸±±¾©»¯¹¤085600 310·ÖÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
Ò»Ö¾Ô¸0817»¯Ñ§¹¤³ÌÓë¼¼Êõ£¬Çóµ÷¼Á
ÒѾÓÐ28È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
¹ØÓÚ2012Ä깫Åɳö¹úÁôѧӢÓïÅàѵ°àµÄÎÊÌâ
ÒѾÓÐ12È˻ظ´
¹ØÓÚ°¢Ë¹°ÍÌðµÄ°²È«ÐÔÎÊÌâ
ÒѾÓÐ12È˻ظ´
¹ØÓÚ¹¤ÒµÉú²úLDAµÄ¼ÓÁÏÎÊÌâ
ÒѾÓÐ5È˻ظ´
¹ØÓÚþºÏ½ð¸¯Ê´µÄÎÊÌâ
ÒѾÓÐ11È˻ظ´
Çë½Ì¹ØÓÚÏÞÏîÎÊÌâ
ÒѾÓÐ5È˻ظ´
¹ØÓÚCSCÍâÓï²¹³ä֪ͨ½â¶ÁºÍÎҵĵ¹ú´óѧÑûÇ뺯µÄÒ»¸öÎÊÌâ
ÒѾÓÐ3È˻ظ´
¹ØÓÚÁ¿»¯¼ÆËãдÎÄÕÂͶ¸åµÄÎÊÌâ
ÒѾÓÐ14È˻ظ´
¹ØÓÚ»ªÈ˵¼Ê¦µÄÎÊÌâ
ÒѾÓÐ29È˻ظ´
¹ØÓÚ¼¤¹âµÄÁ½¸öÎÊÌâ
ÒѾÓÐ7È˻ظ´
¹ØÓÚ¸ÐÊÜÌ¬ÖÆ±¸ÎÊÌâÇë½Ì
ÒѾÓÐ13È˻ظ´
¹ØÓÚ¹âÏ˺͹âÔ´ñîºÏµÄÎÊÌâ
ÒѾÓÐ9È˻ظ´
¹ØÓڸ߷Ö×ÓÁ¿¾Û±ûÏ©õ£°·µÄhofmann½µ½âµÄÎÊÌâ
ÒѾÓÐ3È˻ظ´
¿ìҪץ¿ñÁË£¬Çë½ÌÒ»¸ö¹ØÓÚENDNOTEÖúÊÖµÄʹÓÃÎÊÌâ
ÒѾÓÐ3È˻ظ´
¹ØÓÚxp°²×°ipv6µÄÎÊÌ⣬ÅθßÊÖ°ïæ~~~
ÒѾÓÐ6È˻ظ´
¹ØÓÚPVDÍ˶ƵÄһЩÎÊÌâ
ÒѾÓÐ3È˻ظ´
Journal of Alzheimer's Disease ( impact factor 5.1) µÄÖ÷±à±»³µ×²ËÀÁË
ÒѾÓÐ38È˻ظ´
shy2400
ľ³æ (ÖøÃûдÊÖ)
- SEPI: 2
- Ó¦Öú: 234 (´óѧÉú)
- ¹ó±ö: 0.196
- ½ð±Ò: 4708.4
- É¢½ð: 253
- ºì»¨: 8
- Ìû×Ó: 1276
- ÔÚÏß: 180.8Сʱ
- ³æºÅ: 990305
- ×¢²á: 2010-04-06
- ÐÔ±ð: GG
- רҵ: ¼ÆËã»úÓ¦Óü¼Êõ

3Â¥2012-02-10 16:04:26
xenopus
ľ³æ (ÕýʽдÊÖ)
- Ó¦Öú: 32 (СѧÉú)
- ½ð±Ò: 7174.2
- ºì»¨: 5
- Ìû×Ó: 461
- ÔÚÏß: 883Сʱ
- ³æºÅ: 500347
- ×¢²á: 2008-02-13
- רҵ: ·¢ÓýÉúÎïѧ
2Â¥2012-02-10 16:00:40














»Ø¸´´ËÂ¥
120